your market intelligence analyst
Search Results
Edit Save
1,659 results
FiercePharmaManufacturing 12/06/2019 09:47
In June, a U.S. district court judge temporarily shielded Novartis’ $3 billion-a-year multiple sclerosis drug Gilenya from generic competition—but that’s not preventing generics makers from lining up at the starting gate. Thursday, the FDA approved the first three generic versions of Gilenya, which will be made by HEC Pharm, Biocon and Sun Pharmaceutical.
FiercePharmaManufacturing 12/05/2019 11:24
When Acadia trumpeted news that it would end a late-stage trial for its Nuplazid in dementia-related psychosis (DRP) early, it represented a big win for a drugmaker still stinging from a major schizophrenia flop. Now, data from that trial are giving some analysts hope that Nuplazid could hit blockbuster heights––with or without schizophrenia.
FiercePharmaManufacturing 12/04/2019 10:56
The DOJ's generics price fixing probe has been playing out for years, and this week authorities unveiled a new settlement with the small drugmaker Rising Pharmaceuticals. Rising admitted to price fixing and working with a competitor to rig the market for its hypertension med. It also agreed to cooperate in an ongoing criminal investigation.
FiercePharmaManufacturing 12/04/2019 10:22
Amgen signed a deal with pharmacy benefits manager Abarca that ties reimbursement for its rheumatoid arthritis blockbuster Enbrel to patients' willingness to stay on the drug for the long term. The company could be open to more such outcomes-based deals as the drug faces competition from biosimilars and next-generation RA drugs.

Chemicals - Agricultural

Chemicals - Industrial

Business Issues

Companies - Public

Companies - Venture Funded

Commodity Prices

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities


Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications